Why the study?
Do antiplatelet agents or oral anticoagulants prevent aorto-coronary bypass occlusion in patients undergoing venous bypass grafts?
Population
Patients undergoing aorto-coronary artery venous bypass grafts
Design
Review
Follow-up
6 to 12 months
Authors
Loading...
May support dipyridamole-aspirin over delayed anticoagulants for graft patency; leaves open confirmation in randomized trials.
Do antiplatelet agents or oral anticoagulants prevent aorto-coronary bypass occlusion in patients undergoing venous bypass grafts?
Dipyridamole combined with aspirin appears to be the most effective regimen for preventing aorto-coronary venous bypass graft occlusion, while oral anticoagulants show no significant benefit.
Verstraete et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: